npj Vaccines

Article	Citations
Assessing immunogenicity barriers of the HIV-1 envelope trimer	222
Immunogenicity phase II study evaluating booster capacity of nonadjuvanted AKS-452 SARS-Cov-2 RBD Fc vaccine	142
Vaccination against Onchocerca volvulus induces IgG-mediated protective immunity dependent on neutrophils and complement	125
The dengue-specific immune response and antibody identification with machine learning	117
Risk assessment of retinal vascular occlusion after COVID-19 vaccination	110
Impact of genotypic variability of measles virus T-cell epitopes on vaccine-induced T-cell immunity	97
Reverse development of vaccines against antimicrobial-resistant pathogens	94
Immunogenicity and safety of a rabies-based highly pathogenic influenza A virus H5 vaccine in cattle	87
Analyzing atomic force microscopy images of virus-like particles by expectation-maximization	80
Influenza A virus in dairy cattle: infection biology and potential mammary gland-targeted vaccines	80
A potent and durable malaria transmission-blocking vaccine designed from a single-component 60-copy Pfs230D1 nanoparticle	77
Zika purified inactivated virus (ZPIV) vaccine reduced vertical transmission in pregnant immunocompetent mice	75
Rational development of a combined mRNA vaccine against COVID-19 and influenza	69
Intranasal vaccine for Lyme disease provides protection against tick transmitted Borrelia burgdorferi beyond one year	69
Effective vaccination strategy using SARS-CoV-2 spike cocktail against Omicron and other variants of concern	68
Protein engineering strategies for rational immunogen design	65
Tetravalent microprojection-based dengue chimeric virus vaccine raises potent neutralising antibodies in mice	63
A viral codon usage strategy enhances antigen production and protection in SFTSV mRNA vaccination	63
Immunogenic arenavirus vector SIV vaccine reduces setpoint viral load in SIV-challenged rhesus monkeys	62
Mapping global public perspectives on mRNA vaccines and therapeutics	60
Functionality and translation fidelity characterization of mRNA vaccines using platform based mass spectrometry detection	59
Safety and immunogenicity of the Sm-p80 GLA-SE schistosomiasis vaccine	59
Baseline mapping of Oropouche virology, epidemiology, therapeutics, and vaccine research and development	58
Microneedle patch as a new platform to effectively deliver inactivated polio vaccine and inactivated rotavirus vaccine	55
Single-dose intranasal adenovirus-based RSV vaccines targeting G and M2	54

Diversity of immunization strongly impacts SARS-CoV-2 antibody function surrogates	54
Genome-wide association study of myocarditis and pericarditis following COVID-19 vaccination	54
Author Correction: A Pvs25 mRNA vaccine induces complete and durable transmission-blocking immunity to Plasmodium vivax	53
Next-gen novel nanocage-based multivalent vaccine candidate to tackle the rising menace of Mpox	52
IL-12 mRNA-LNP promotes dermal resident memory CD4+ T cell development	50
Tick-borne encephalitis vaccine breakthrough infections induce aberrant T cell and antibody responses to non-structural proteins	49
Immunogenicity and protective efficacy of a rhesus adenoviral vaccine targeting conserved COVID-19 replication transcription complex	48
Restricted valency (NPNA)n repeats and junctional epitope-based circumsporozoite protein vaccines against Plasmodium falciparum	48
LmCen−/− based vaccine is protective against canine visceral leishmaniasis following three natural exposures in Tunisia	47
Leishmania tarentolae as a platform for the production of vaccines against viral pathogens	47
Vaccination with Mincle agonist UM-1098 and mycobacterial antigens induces protective Th1 and Th17 responses	46
A register and questionnaire study of long-term general health symptoms following SARS-CoV-2 vaccination in Denmark	46
PfRH5 vaccine; from the bench to the vial	46
SARS-CoV-2 vaccination may mitigate dysregulation of IL-1/IL-18 and gastrointestinal symptoms of the post-COVID-19 condition	44
Use of equine H3N8 hemagglutinin as a broadly protective influenza vaccine immunogen	44
GP38 as a vaccine target for Crimean-Congo hemorrhagic fever virus	43
A field test of empathetic refutational and motivational interviewing to address vaccine hesitancy among patients	43
Immunogenicity and efficacy of homologous and heterologous NDV and MVA SARS-CoV-2 vaccines in mice and hamsters	43
A rationally designed antigen elicits protective antibodies against multiple nosocomial Gram-positive pathogens	43
Antibody responses against influenza A decline with successive years of annual influenza vaccination	40
Multivalent cytomegalovirus glycoprotein B nucleoside modified mRNA vaccines did not demonstrate a greater antibody breadth	39
Multicomponent intranasal adjuvant for mucosal and durable systemic SARS-CoV-2 immunity in young and aged mice	39
Immune response induced by standard and fractional doses of 17DD yellow fever vaccine	38
Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants	37
Human in vitro modeling of adjuvant formulations demonstrates enhancement of immune responses to SARS-CoV-2 antigen	37
Effect of monovalent COVID-19 vaccines on viral interference between SARS-CoV-2 and several DNA viruses in patients with long-COVID syndrome	36
Conjugation of HIV-1 envelope to hepatitis B surface antigen alters vaccine responses in rhesus macaques	36
Recombinant lipidated FLIPr effectively enhances mucosal and systemic immune responses for various vaccine types	36
Mobilizing domestic support for international vaccine solidarity – recommendations for health crisis communication	35
Impact of COVID-19 vaccination coverage on global disability burden of Guillain-Barré syndrome	35
Dithranol as novel co-adjuvant for non-invasive dermal vaccination	34
Divergence of variant antibodies following SARS-CoV-2 booster vaccines in myeloma and impact of hybrid immunity	34
Vaccination of cattle with the Babesia bovis sexual-stage protein HAP2 abrogates parasite transmission by Rhipicephalus microplus ticks	34
An anti-LpqH human monoclonal antibody from an asymptomatic individual mediates protection against Mycobacterium tuberculosis	33
Intranasal COVID-19 vaccine induces respiratory memory T cells and protects K18-hACE mice against SARS-CoV-2 infection	33
An epitope-optimized human H3N2 influenza vaccine induces broadly protective immunity in mice and ferrets	33
A protective measles virus-derived vaccine inducing long-lasting immune responses against influenza A virus H7N9	33
Self-assembling SARS-CoV-2 spike-HBsAg nanoparticles elicit potent and durable neutralizing antibody responses via genetic delivery	32
Toxin expression during Staphylococcus aureus infection imprints host immunity to inhibit vaccine efficacy	32
Neoantigen-augmented iPSC cancer vaccine combined with radiotherapy promotes antitumor immunity in poorly immunogenic cancers	31
A safe insect-based chikungunya fever vaccine affords rapid and durable protection in cynomolgus macaques	31
Urgency and necessity of Epstein-Barr virus prophylactic vaccines	31
Mucosal administration of a live attenuated recombinant COVID-19 vaccine protects nonhuman primates from SARS-CoV-2	30
A therapeutic hepatitis B mRNA vaccine with strong immunogenicity and persistent virological suppression	30
Bivalent norovirus mRNA vaccine elicits cellular and humoral responses protecting human enteroids from GII.4 infection	30
Potent and long-lasting humoral and cellular immunity against varicella zoster virus induced by mRNA-LNP vaccine	30
Single dose VSV-based vaccine protects mice against lethal heterologous Crimean-Congo hemorrhagic fever virus challenge	29
Assessing the impact of mRNA vaccination in chronic inflammatory murine model	28
Author Correction: Regulatory review of benefits and risks of preventing infant RSV disease through maternal immunization	28
Sequential immunization with chimeric hemagglutinin ΔNS1 attenuated influenza vaccines induces broad humoral and cellular immunity	28

Modulation of oral vaccine efficacy by the gut microbiota	28
Enhanced attenuation of chikungunya vaccines expressing antiviral cytokines	27
Continuing development of vaccines and monoclonal antibodies against Zika virus	26
Immunogenicity of 2 therapeutic mosaic HIV-1 vaccine strategies in individuals with HIV-1 on antiretroviral therapy	26
The Streptococcus pyogenes vaccine landscape	26
Strep A: challenges, opportunities, vaccine-based solutions, and economics	26
A candidate subunit vaccine induces protective immunity against Mycobacterium avium subspecies paratuberculosis in mice	26
WHO International Standards for antibodies to HPV6 HPV11 HPV31 HPV33 HPV45 HPV52 and HPV58	26
Engineering the hydroxyl content on aluminum oxyhydroxide nanorod for elucidating the antigen adsorption behavior	26
C5aR+ dendritic cells fine-tune the Peyer’s patch microenvironment to induce antigen-specific CD8+ T cells	26
Long term T cell response and safety of a tetravalent dengue vaccine in healthy children	26
A broadly protective vaccine against cutaneous human papillomaviruses	26
Optimal deployment of limited vaccine supplies to control mpox outbreaks	25
Realising the potential of correlates of protection for vaccine development, licensure and use: short summary	25
Novel oral adjuvant to enhance cytotoxic memory like NK cell responses in HIV vaccine platform	25
Immunogenic recombinant Mayaro virus-like particles present natively assembled glycoprotein	25
A safe and potentiated multi-type HPV L2-E7 nanoparticle vaccine with combined prophylactic and therapeutic activity	25
mRNA vaccines induce rapid antibody responses in mice	24
Replication in human cells supersedes serum antigenic match for the in vivo efficacy of an A/H1N1pdm09 LAIV virus	24
MVA-based vaccine candidates encoding the native or prefusion-stabilized SARS-CoV-2 spike reveal differential immunogenicity in humans	24
The TLR7/8 agonist INI-4001 enhances the immunogenicity of a Powassan virus-like-particle vaccine	24
COVID-19 vaccination induces distinct T-cell responses in pediatric solid organ transplant recipients and immunocompetent children	24
Toxoplasmosis vaccines: what we have and where to go?	24
Broad protection and respiratory immunity of dual mRNA vaccination against SARS-CoV-2 variants	24
Intranasal vaccination with an NDV-vectored SARS-CoV-2 vaccine protects against Delta and Omicron challenges	24
Antigen identification strategies and preclinical evaluation models for advancing tuberculosis vaccine development	23
Analyzing immune responses to varied mRNA and protein vaccine sequences	23
Transcriptional signature of durable effector T cells elicited by a replication defective HCMV vaccine	23
Esoteric beliefs and CAM impact SARS-CoV-2 immunization drivers, uptake and pediatric immunization views in Germany	23
Establishing an immune correlate of protection for Nipah virus in nonhuman primates	23
Retraction Note: Efficacy and immunogenicity of MultiTEP-based DNA vaccines targeting human α-synuclein: prelude for IND enabling studies	23
mRNA vaccines expressing malaria transmission-blocking antigens Pfs25 and Pfs230D1 induce a functional immune response	22
Comparison of rArt v 1-based sublingual and subcutaneous immunotherapy in a murine model of asthma	22
Multifunctional IgG/IgM antibodies and cellular cytotoxicity are elicited by the full-length MSP1 SumayaVac-1 malaria vaccine	22
Elicitation of liver-stage immunity by nanoparticle immunogens displaying P. falciparum CSP-derived antigens	22
Chimeric hemagglutinin and M2 mRNA vaccine for broad influenza subtype protection	22
Live-attenuated ME49Δcdpk3 strain of Toxoplasma gondii protects against acute and chronic toxoplasmosis	22
Deglycosylation of eukaryotic-expressed flagellin restores adjuvanticity	22
Moderate to severe SARS-CoV-2 infection primes vaccine-induced immunity more effectively than asymptomatic or mild infection	22
Accelerating the manufacturing of HIV Env protein vaccines for early phase clinical evaluation	21
Impact of inactivated vaccine on transmission and evolution of H9N2 avian influenza virus in chickens	21
Streptococcus pyogenes vaccine candidates do not induce autoimmune responses in a rheumatic heart disease model	21
Author Correction: Immunogenicity and safety of an intradermal ChAdOx1 nCoV-19 boost in a healthy population	21
Pre-existing antibodies directed against a tetramerizing domain enhance the immune response against artificially stabilized soluble tetrameric influenza neuraminidase	21
A lipidated TLR7/8 adjuvant enhances the efficacy of a vaccine against fentanyl in mice	21
Rapid emergence and transmission of virulence-associated mutations in the oral poliovirus vaccine following vaccination campaigns	21
The need for a clinical case definition in test-negative design studies estimating vaccine effectiveness	21
Computationally designed Spike antigens induce neutralising responses against the breadth of SARS-COV-2 variants	21
Cocktail vaccine induces immunoprotection and modulates the fecal microbiota in dogs against Echinococcus granulosus infection	21
Cellular immune breadth of an Omicron-specific, self-amplifying monovalent mRNA vaccine booster for COVID-19	21
COVID-19 and influenza vaccine uptake among pregnant women in national cohorts of England and Wales	21
An attachment glycoprotein nanoparticle elicits broadly neutralizing antibodies and protects against lethal Nipah virus infection	21
B cells oppose Mycoplasma pneumoniae vaccine enhanced disease and limit bacterial colonization of the lungs	21
Adenovirus type 5-expressing Gn induces better protective immunity than Gc against SFTSV infection in mice	21
Modified influenza M158–66 peptide vaccination induces non-relevant T-cells and may enhance pathology after challenge	20
An engineered HIV-1 Gag-based VLP displaying high antigen density induces strong antibody-dependent functional immune responses	20
A highly immunogenic UVC inactivated Sabin based polio vaccine	20
Genetic ancestry and population structure of vaccinia virus	20
Immunogenicity and reactogenicity of intradermal mRNA-1273 SARS-CoV-2 vaccination: a non-inferiority, randomized-controlled trial	20
Assessments of different batches and dose levels of a two-dose Ad26.ZEBOV and MVA-BN-Filo vaccine regimen	20
Is new dengue vaccine efficacy data a relief or cause for concern?	20
A highly immunogenic vaccine platform against encapsulated pathogens using chimeric probiotic Escherichia coli membrane vesicles	20
Long-term outcome of patients with vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis	20
The scientific journey of a novel adjuvant (AS37) from bench to bedside	19
Safety and immunogenicity of SARS-CoV-2 vaccine MVC-COV1901 in Taiwanese adolescents: a randomized phase 2 trial	19
Unique features of a recombinant haemagglutinin influenza vaccine that influence vaccine performance	19
HPV16 infection decreases vaccine-induced HPV16 antibody avidity: the CVT trial	19
Long-term efficacy of an inactivated H5N1 whole-particle influenza vaccine in nonhuman primates	19
Polyfunctional CD4 T-cells correlating with neutralising antibody is a hallmark of COVISHIELDTM and COVAXIN® induced immunity in COVID-19 exposed Indians	19
Identifying Plasmodium P36 and P52 antigens for coadministration with circumsporozoite protein to enhance vaccine efficacy	19
A scoping review of global COVID-19 vaccine hesitancy among pregnant persons	19
The full health, economic, and social benefits of prospective Strep A vaccination	19
Impact of yellow fever virus envelope protein on wild-type and vaccine epitopes and tissue tropism	19
NHBA antibodies elicited by 4CMenB vaccination are key for serum bactericidal activity against Neisseria gonorrhoeae	19
Intranasal influenza-vectored vaccine expressing pneumococcal surface protein A protects against Influenza and Streptococcus pneumoniae infections	19
Therapeutic efficacy of an Ad26/MVA vaccine with SIV gp140 protein and vesatolimod in ART-suppressed rhesus macaques	19
Safety and efficacy of C. muridarum vaccines adjuvanted with CpG-1826 and four concentrations of Montanide-ISA-720-VG	19
Persistence of hepatitis E vaccine-induced antibody response across different dosage schedules and baseline serostatus	18
Modular assembly and immunological evaluation of a promising bioconjugate nanovaccine against Klebsiella pneumoniae O2 serotype	18
Long-term trial of protection provided by adenovirus-vectored vaccine expressing the PPRV H protein	18

Cancer type and gene signatures associated with breakthrough infections following COVID-19 mRNA vaccination	18
mRNA vaccines with RBD mutations have broad-spectrum activity against SARS-CoV-2 variants in mice	18
Intranasal immunization with avian paramyxovirus type 3 expressing SARS-CoV-2 spike protein protects hamsters against SARS-CoV-2	18
Author Correction: Selectively targeting haemagglutinin antigen to chicken CD83 receptor induces faster and stronger immunity against avian influenza	17
Immunogenicity, immune persistence, and safety of japanese encephalitis vaccine schedules among adults in Ningxia, China	17
Adverse effects, perceptions and attitudes related to BNT162b2, mRNA-1273 or JNJ-78436735 SARS-CoV-2 vaccines: Population-based cohort	17
Proof of concept for a single-dose Group B Streptococcus vaccine based on capsular polysaccharide conjugated to Qβ virus-like particles	17
Human naïve B cells show evidence of anergy and clonal redemption following vaccination	17
Author Correction: Establishing a universal IVRP method for quadrivalent HPV vaccines to replace in vivo potency tests	17
Distinct dynamics of mRNA LNPs in mice and nonhuman primates revealed by in vivo imaging	17
Evaluation of mRNA-LNP and adjuvanted protein SARS-CoV-2 vaccines in a maternal antibody mouse model	17
Impact of mandatory vaccination against serogroup C meningococci in targeted and non-targeted populations in France	17
Publisher Correction: Modeling gonorrhea vaccination to find optimal targeting strategies that balance impact with cost-effectiveness	17
Factors influencing long-term persistence of anti-HBs after hepatitis B vaccination	17
Precocious Eimeria magna transgenically expressing RHDV P2 subdomain induces immune responses in rabbits	17
Calibrated comparison of SARS-CoV-2 neutralizing antibody levels in response to protein-, mRNA-, and vector-based COVID-19 vaccines	17
Author Correction: The dengue-specific immune response and antibody identification with machine learning	17
Inverted H1 hemagglutinin nanoparticle vaccines protect mice against challenges with human H1N1 and bovine H5N1 influenza viruses	17
A randomised trial of malaria vaccine R21/Matrix-M™ with and without antimalarial drugs in Thai adults	17
Progress with COVID vaccine development and implementation	17
Vaccine-induced time- and age-dependent mucosal immunity to gastrointestinal parasite infection	17
A broad spectrum Shigella vaccine based on VirG53–353 multiepitope region produced in a cell-free system	17
Publisher Correction: AI-driven epitope prediction: a systematic review, comparative analysis, and practical guide for vaccine development	17
To generate functional anti-protease-activated receptor-4 (PAR4), a G protein-coupled receptor, antibodies through PAR4-mRNA-LNP immunization	17
A single intranasal dose of human parainfluenza virus type 3-vectored vaccine induces effective antibody and memory T cell response in the lungs and protects hamsters against SARS-CoV-2	17
Filovirus vaccines as a response paradigm for emerging infectious diseases	16
Optimization of an alum-anchored clinical HIV vaccine candidate	16
Correlates of immunity to Group A Streptococcus: a pathway to vaccine development	16
Gut microbiota modulate immune responses to orally and parenterally administered rotavirus in mice	16
Divergent B-cell repertoire remodelling by mRNA, DNA and live attenuated vaccines in fish	16
CD4 T cell epitope abundance in ferritin core potentiates responses to hemagglutinin nanoparticle vaccines	16
Systematic review of primary and booster COVID-19 sera neutralizing ability against SARS-CoV-2 omicron variant	16
Loop structure in poly(A) tail of mRNA vaccine enhances antigen translation efficiency and mRNA stability	16
A centralised immunogen approach to develop a more broadly protective modified live porcine reproductive and respiratory syndrome virus 1 vaccine candidate	16
Cyclic di AMP phosphodiesterase nanovaccine elicits protective immunity against Burkholderia cenocepacia infection in mice	16
Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in mice	16
A chimeric thermostable M2e and H3 stalk-based universal influenza A virus vaccine	16
Elucidating functional epitopes within the N-terminal region of malaria transmission blocking vaccine antigen Pfs230	16
iDC-targeting PfCSP mRNA vaccine confers superior protection against Plasmodium compared to conventional mRNA	15
A virus-like particle-based bivalent PCSK9 vaccine lowers LDL-cholesterol levels in non-human primates	15
A phase I clinical study to assess safety and immunogenicity of yellow fever vaccine	15
ASP-2/Trans-sialidase chimeric protein induces robust protective immunity in experimental models of Chagas’ disease	15
Systematic review of evidence on feasibility of administering intranasal live attenuated influenza vaccine at home	15
Author Correction: Development of molecular clamp stabilized hemagglutinin vaccines for Influenza A viruses	15
An adjuvanted zoster vaccine elicits potent cellular immune responses in mice without QS21	15
Systems vaccinology identifies immunological correlates of SARS-CoV-2 vaccine response in solid organ transplant recipients	15
A functional enzymatic assay as potential readout for a clinical trial of a schistosomiasis vaccine	15
Predicted effectiveness of vaccines and extended half-life monoclonal antibodies against RSV hospitalizations in children	15
Neoantigen cancer vaccine augments anti-CTLA-4 efficacy	15
Reproducible and later vaccine strain selection can improve vaccine match to A/H3N2 seasonal influenza viruses	15
Transcriptome signatures preceding the induction of anti-stalk antibodies elicited after universal influenza vaccination	15
The immunological interplay between vaccination and the intestinal microbiota	15
An intranasal combination vaccine induces systemic and mucosal immunity against COVID-19 and influenza	15
OpcA and PorB are novel bactericidal antigens of the 4CMenB vaccine in mice and humans	15
Applying causal inference and Bayesian statistics to understanding vaccine safety signals using a simulation study	14
Risk analysis for outpatient experimental infection as a pathway for affordable RSV vaccine development	14
Irradiated whole cell Chlamydia vaccine confers significant protection in a murine genital tract challenge model	14
Persistent immunogenicity of integrase defective lentiviral vectors delivering membrane-tethered native-like HIV-1 envelope trimers	14
Identifying vaccine-hesitant subgroups in the Western Pacific using latent class analysis	14
A mosaic influenza virus-like particles vaccine provides broad humoral and cellular immune responses against influenza A viruses	14
The potential global cost-effectiveness of prospective Strep A vaccines and associated implementation efforts	14
A DNA vaccine candidate delivered by an electroacupuncture machine provides protective immunity against SARS-CoV-2 infection	14
Affordable SARS-CoV-2 protein vaccines for the pandemic endgame	14
Autologous dendritic cell vaccination against HIV-1 induces changes in natural killer cell phenotype and functionality	14
Proteomic approach to identify host cell attachment proteins provides protective Pseudomonas aeruginosa vaccine antigen FtsZ	14
A Rift Valley fever mRNA vaccine elicits strong immune responses in mice and rhesus macaques	14
Publisher Correction: Carbohydrate fatty acid monosulphate: oil-in-water adjuvant enhances SARS-CoV-2 RBD nanoparticle-induced immunogenicity and protection in mice	14
Level of antibody to hepatitis B surface antigen declined below 10 mIU/ml is still protective	14
Booster vaccination with Ad26.COV2.S or an Omicron-adapted vaccine in pre-immune hamsters protects against Omicron BA.2	14
Mass cytometry reveals cellular correlates of immune response heterogeneity to SARS-CoV-2 vaccination in the elderly	14
Pro-inflammatory cytokine profiles and neutralizing antibodies in JYNNEOS-vaccinated and mpox-diagnosed individuals	14